Project Grant K01DA064840
- Federal Grant Award Summary Boston Medical Center Corporation received a $269,394 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 15, 2025, through June 30, 2030. The award funds the Clinical Undergraduate Research in Addictions – Training and Experiences (CURATE) Program, which develops and delivers a 10-week summer research training program for undergraduate students nationwide. The program...
- Federal Project Grant Award Summary Baystate Medical Center, Inc. received a $187,023 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, with a completion date of August 31, 2030. This mentored research career development award funds a mixed-methods study evaluating Massachusetts's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program, a statewide Medicaid initiative...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a Project Grant totaling $144,252 to the University of Massachusetts Medical School (UMMS) under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 1, 2025, with a completion date of August 31, 2030. This mentoring-focused award supports Dr. Carreiro's research program in precision medicine and digital biomarkers for opioid use disorder (OUD) prevention and treatment. The grant funds three integrated...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital a $197,640 Project Grant on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a four-year clinical and economic research initiative through February 28, 2030. This award supports research designed to evaluate the clinical impact and cost-effectiveness of integrating infectious disease (ID) care into rapid-access substance use disorder...
- Federal Project Grant Award Summary Boston University Medical Campus received a $193,752 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective February 15, 2026 through January 31, 2031. The award supports research on adolescent exposure to nicotine and tobacco product (NTP) content on social media platforms by incorporating youth experiences and social media analytics to improve exposure assessment...
- Federal Project Grant Award Summary Boston University Medical Campus received a $109,076 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective January 9, 2026, with completion targeted for July 31, 2029. The award supports basic research investigating the role of G Alpha Z (GAZ) protein in mediating behavioral responses to opioids, with the objective of identifying signaling pathways that promote pain...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Mentored Research Scientist Development Award (K01) totaling $399,600 under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year career development and mentored research initiative. Awarded on August 15, 2025, with completion targeted for July 31, 2030, this grant funds Dr. Jason Brian Gibbons at the University of Colorado Anschutz Medical Campus to develop machine learning-based...
- Federal Grant Award Summary The University of Massachusetts Medical School received a $1.5M Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through May 31, 2030. The award funds the COLAAB (Clinical Organization and Legal Agency Alliance Building) Study, an implementation science research initiative designed to improve access to Medications for Opioid Use Disorder (MOUD) within drug court...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Grant Award Summary Boston University Medical Campus received a $1.48M project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the BUP-BOOSTER optimization trial. The award, obligated on September 30, 2025, with a completion date of May 31, 2030, funds development and evaluation of a multicomponent behavioral intervention designed to improve buprenorphine treatment retention among individuals with opioid...
Boston University received a $193,751 Career Development Award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning May 1, 2026 and concluding April 30, 2031. This grant supports the development of an independent researcher focused on improving substance use disorder (SUD) services through a rigorous training and research program. The primary deliverables include research examining variation in quality of care among outpatient SUD treatment facilities, identifying organizational and service delivery factors associated with high-quality treatment, and assessing whether Medicaid pay-for-performance initiatives improve facility-level quality outcomes. The research leverages a novel dataset linking 2016-2024 Medicaid claims with SUD treatment facility data to address critical gaps in quality measurement for the nation's outpatient SUD treatment landscape. The award supports structured mentoring and didactic training in four key areas: management and analysis of complex datasets, quality measurement methods, financing and payment models, and SUD services research. These research and training products are designed to establish the awardee as an independent SUD services researcher capable of driving large-scale improvements in the quality of care delivery for Medicaid enrollees in outpatient settings, with direct application to addressing the ongoing overdose crisis affecting the United States.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $193.8k | 2/12/26 |